µ±Ç°Î»ÖãºÐ¡Ä¾³æÊ×Ò³ >> ÐÂÒ©Ñз¢

ÇóÖúRETÈÚºÏÒÖÖÆ¼ÁTPX-0046µÄ·Ö×Óʽ¼°CASºÅÐÅÏ¢

yol_11
ÇóÖúRETÈÚºÏÒÖÖÆ¼ÁTPX-0046µÄ·Ö×Óʽ¼°CASºÅÐÅÏ¢£¬¶àл£¡

ÄÆº¬Á¿ÈçºÎÉ趨

lihu692
²úÆ·±¾ÉíÊÇÄÆÑΣ¬ÀíÂÛֵΪ4.8%£¬ÈçºÎÖÆ¶¨Äƺ¬Á¿µÄÖÊÁ¿±ê×¼£¬²»ÖªÓÐʲô·¨¹æ»òÒ©µä¹æ¶¨£¬¸ÃÈçºÎÉ趨·¶Î§£¿Ð»Ð»

Ò»ÖÂÐÔÆÀ¼ÛµÄÎÊÌâÏëÇë½Ìǰ±²£¬ÍûÖ¸µã£¬Ð»Ð»£¡

ÌìÑÄõ¹åÎÒ¶¼·îÅ
»¯Ò©Ò»ÖÂÐÔÆÀ¼Û£¬²Î±ÈÖÆ¼ÁÊǶ³¸É·ÛºÍ×¢ÉäÓÃË®·Ö×°£¬¹«Ë¾×Ô¼ºµÄÆ·ÖÖĿǰֻÓж³¸É·Û£¬µ«ÊÇÕâ´ÎÒ»ÖÂÐÔÆÀ¼ÛÏë°Ñ¶³¸É·ÛºÍ×¢ÉäÓÃˮһÆð±¨ÉÏÈ¥£¬×¢ÉäÓÃË®ÊÇÖ±½ÓÂò±ðµÄ¹«Ë¾ºÏ¸ñ²úÆ·£¬µ«ÊÇ×Ô¼º¹«Ë¾Ö»×öÁ˶³¸É·ÛÏàÓ¦µÄ¸÷ÖÖʵÑ飬²¢Ã»ÓÐ×öÖ±½Ó¹ºÂòµÄ×¢ÉäÓÃË®µÄÊÔÑ飬ÕâÖÖÇé¿öµÄ»°£¬¿ÉÒÔÒ»ÆðÉê...

ƵÄÄ´¼ÏÞ¶È¿ØÖÆ£ºÓÉLD50¼ÆËãPDE

My name is
²éѯƵÄÄ´¼Êý¾Ý£ºLD50:СÊó¿Ú·þ3380mg/kg£¬Î´»ñµÃÆäËûÊý¾Ý¸ù¾Ý¡¶APICÔ­ÁÏÒ©¹¤³§ÖÐÇå½àÑéÖ¤Ö¸ÄÏ(2016°æ)¡·Öй«Ê½ºÍÎÄÏ×¼ÆËãNOEL:NOEL=LD50/2000=3380mg/kg/2000=1.69mg/kgÉÏÊö¹«Ê½µ¥Î»¶Ô²»ÉÏ£¬ÒòNOELµ¥Î»...

IND½×¶Î²ÐÁôÈܼÁÒªÇó

zlh0604
INDÉ걨½×¶Înon-GMPºÍGMPÑùÆ·ÖÐÓÐÒ»¸öÈýÀà²ÐÁôÈܼÁ³¬±ê£¬¹¤ÒÕÔÝʱÎÞ·¨½µµ½ÏÞ¶ÈÖ®ÄÚ£¬µ«µÍÓÚ¶¾ÀíÅú²ÐÁôÈܼÁÏÞ¶È£¬ÇëÎÊÉ걨INDÊÇ·ñÓзçÏÕ

ÖÐÒ©¸Ä¼ÁÐÍÈçºÎÖ¤Ã÷¡°´æÔÚÃ÷ÏÔÁÙ´²Ó¦ÓüÛÖµ¡±£¿

alex2000
ÎÒÃÇÕâÀïÒÔǰÓÐÒ»¸öÖÐÒ©¸Ä¼ÁÐÍÉ걨ʧ°ÜÁË£¬ÉóÅúÒâ¼ûÊÇ¡°Î´ÌṩмÁÐÍÓëÔ­¼ÁÐÍÏà±È´æÔÚÃ÷ÏÔÁÙ´²Ó¦ÓüÛÖµµÄÒÀ¾Ý£¬ÏÖÓÐÉ걨×ÊÁÏÄÑÒÔ˵Ã÷±¾Æ·¸Ä¼ÁÐ͵ıØÒªÐԺͺÏÀíÐÔ¡±Çë½ÌÏÂӦͨ¹ýʲôÊý¾Ý»ò×ÊÁÏÖ¤Ã÷мÁÐÍÓëÔ­¼ÁÐÍÏà±È´æÔÚÃ÷ÏÔÁÙ´²Ó¦ÓüÛÖµ£¿ÈçºÎÖ¤Ã÷±ØÒªÐԺͺÏÀíÐÔ£¿Ò»¶¨ÒªÐ¼ÁÐ͵Ä...

Ò©Îï¹ÌÌå·ÖÉ¢ÌåÌåÍâÈܳöÇúÏßÔÚ20minʱ³öÏÖµøÂäÏÖÏó£¬ÀÛ»ýÈܳö²îÒì½Ï´ó

רע¿ÄÑÎ
ÏÖÔÚÔÚ×öÒ»¸öËÙÊÍÒ©ÎïµÄ¹ÌÌå·ÖÉ¢Ì壬ҩÎï¹æ¸ñΪ50mg£¬µ«ÊÇΪºÏ³ÉÒ©ÎËùÒÔÑ¡ÔñÌåÍâÈܳöͶҩÁ¿Îª1mg¡£Ñ¡ÔñÔØÌåΪPoloxamer407£¬É¸Ñ¡Ò©Ôرȡ£ÌåÍâÈܳö²ÎÊý£º37¡æ...

ôDZû»ù-¦Â-»·ºý¾«°üºÏÎïÔÓÖÊÓëÖ÷²úÆ·MSÒ»ÖÂ

kggy2003lee
°üºÏÎïÎÊÌâÃèÊöÈçÏ£¬ÇóÖú¸÷λ´óÉñ½â´ðÏ£º1¡¢ôDZû»ù-¦Â-»·ºý¾«°üºÏÎïÔÚ¸ßΣ¨60¡æ£©Ìõ¼þÏ·ÅÖÃ5Ììºó£¬ÓÃÒÒëæ/¶þ¼×ÑÇí¿=4/1ÈÜ½â½øHPLCÑù£¬ÎÒÃÇÐèÒªµÄ²úÆ··åRT=12min£¬ÔÓÖÊ·åRT=8min£¬µ«ÊÇLC-MSÏÔʾÔÓÖÊ·åMSÓë²úÆ··åMSÒ»Ö£¬°ô״ͼҲһÖ¡£...

ÇëÎÊË­ÖªµÀ±±¾©ÄÄÀï¿ÉÒÔ×ö¶þά¸ßЧҺÏàÉ«Æ×ÖÊÆ×£¿

¾²Ë®Á÷Éî8340
ÇëÎÊË­ÖªµÀ±±¾©ÄÄÀï¿ÉÒÔ×ö¶þά¸ßЧҺÏàÉ«Æ×ÖÊÆ×£¿

Äý½ºÌù¸à-ÈÈÈÛ½ººÍÈܼÁ½ºÌùÇóÖú

ÖÁ³ÏÖÁÕæ
×î½üÔÚ×öË®Äý½ºÌù¸à¼Á£¬ÈÈÈÛ½ººÍÈܼÁ½ºÌù¡£Óй²Í¬ÔÚÑо¿£¬»òÕßÓо­ÑéµÄ´óÀÐÂ𣿴ó¼ÒÊÇÈçºÎ×öÄØ¡£ÀïÃæÉæ¼°µ½ºÜ¶à¸ß·Ö×Ó¸¨ÁÏ£¬ÔËÓÃɸѡÈçºÎ½øÐУ¬¸Ã·½Ãæ±È½ÏǷȱ£¬ÓÐÄÇλ´óÀÐÓо­ÑéµÄ£¬Óи¨ÁϵÈÐÅÏ¢£¬»¶Ó­¹²ÏíÏ£¬Íò·Ö¸Ðл¡£

ÖÐÒ©Ë®¼åÒºÈçºÎŨËõ

µØ·½¾ü
ÖÐÒ©Ë®¼åÒºÒ»Ö±ÓÃÐýתÕô·¢ÒÇŨËõ£¬±È½Ï·Ñʱ£¬¿ÉÒÔÓÿª¸Ç¼åÖóµÄ·½·¨Å¨ËõÂð£¿

¶³¸É¹ý³ÌÖк¬Á¿Ëðʧ

Ìý·çµÄº¢×Ó
±¾ÈËÔÚ×öÒ»¸ö¶³¸É·ÂÖÆÒ©£¬°´µ±Ç°¶³¸É¹¤ÒÕ²ÎÊý¶³¸ÉÑùÆ·µÄÐÎ̬£¬pHÓë²Î±ÈÖÆ¼Á¾ùÒ»Ö£¬µ«ÊǺ¬Á¿ÉÙÁË10%×óÓÒ£¬Ä¿Ç°ÒÑÅųýÁËÂËĤÎü¸½£¬¹à×°Ìå»ýÉÙµÈÎÊÌ⣬¶øÇÒÑùÆ··Ö×ÓÁ¿½Ï´óÓ¦¸Ã²»»á»Ó·¢£¬µ«ÊǺ¬Á¿ÉÙÁË¡£×ß¹ý·¹ýµÄ´óÉñÃÇ£¬¸øµã½¨Òé°É¡£

ÕÐÆ¸ºÏ³É£¬Ò©»¯

wendy2021007
ÓÐûÓÐ×öºÏ³ÉºÍÒ©»¯µÄ£¬´óÁ¿ÕÐÆ¸Å¶

TopiramateÔ­ÁÏÒ© USP42-NF37¡¢EP10.5¡¢USP¨CNF 2021(Issue 2)ÖÊÁ¿±ê×¼£¬Ð»Ð»

AnnF
ÇóÖú£ºtopiramateÔ­ÁÏÒ©3¸öÖÊÁ¿±ê×¼£ºusp42-nf37¡¢ep10.5¡¢usp-nf2021(issue2)ллhndc123Ò©µÀÈË

ÈçºÎ²éѯҩÎïµÄ¹úÍâÔ­ÑÐרÀû

sunnydoll9
ÑÎËá¶à°Í°·ÏîÄ¿Á¢Ïîºó£¬Ô­Ñг§¼ÒHospira£¬ÈçºÎ²éѯ¸ÃÒ©ÎïµÄÔ­Ñг§¼ÒµÄÔ­ÑÐרÀûÐÅÏ¢£¿³ÈƤÊé²é¹ý£¬ÓÉÓÚÒѾ­¹ýÆÚÎÊÌ⣬³ÈƤÊéÏÔʾûÓÐ

·¢½Í»òÕß°ëºÏ³ÉÀàÔ­ÁÏÒ©ÓÐÄÄЩ£¿

°Îµ¶Õ«
ÈçÌ⣬һÆð½»Á÷Ï·¢½ÍÀà»òÕß°ëºÏ³ÉÀàµÄÔ­ÁÏÒ©ÓÐÄÄЩ£¿

¡¶Ò©Æ·Éú²ú¼à¶½¹ÜÀí°ì¡· ¡¶Ò©Æ·×¢²á¹ÜÀí°ì·¨¡·

yjs66
Ë­ÓС¶Ò©Æ·Éú²ú¼à¶½¹ÜÀí°ì¡·¡¶Ò©Æ·×¢²á¹ÜÀí°ì·¨¡·×îаæµç×ÓµµÔ­Îļþ£¿ÓеϰÄÜÌṩһ·Ý¸øÎÒÂð£¿

¼ºÍª¿É¿É¼îPentoxifylline¡¶EP10.5¡·µÄÒ©µä±ê×¼Ò»·Ý

fzonghua
Çó¼ºÍª¿É¿É¼îEP10.5±ê×¼Ò»·Ý£¬Pentoxifylline¡¶EP10.5¡·µÄÒ©µä±ê×¼Ò»·Ý

ÇóÊéGreene's Protective Groups in Organic Synthesis, 5th Edition

xiaoding1018
Greene\'sProtectiveGroupsinOrganicSynthesis,5thEditionͼÊé×÷ÕßeterG.M.WutsͼÊé±êÌâ:Greene\\\'sProtectiveGroupsinOrganicSynthesis,5thEditio...

Ò©´ú²ÎÊý¼ÆËã(¹ØÓÚBQLÈ¡Éá)

panyuanfu
ÓÐûÓÐͬÐдóÀУ¬ÏñÕâÖÖÄ©¶Ë²»Ïû³ý£¬È»ºóÖè½µµ½¶¨Á¿ÏÞÒÔϵģ¬BQL»áÔõô´¦ÖÃѽ£¿Çó½»Á÷£¬Ð»Ð»£¡

·ÂÖÆÒ©µÄÕæÏࡪ£¨ÃÀ£©¿­ÉªÁÕ¡¤°£°àÖø ¸ßÌìÓðÒë2020.9³ö°æ

lwjxz
·ÂÖÆÒ©µÄÕæÏࡪ£¨ÃÀ£©¿­ÉªÁÕ¡¤°£°àÖø¸ßÌìÓðÒë2020.9³ö°æÄÚÈݼò½é£º·ÂÖÆÒ©ÊÇÔÚÆ·ÅÆÒ©×¨Àûµ½ÆÚÖ®ºó£¬ºÏ·¨·ÂÖÆ³öÀ´µÄÁ®¼Û°æ±¾¡£¾Ý³ÆËüµÄ³É·Ö¡¢Ð§¹ûÓëÆ·ÅÆÒ©¼¸ºõÒ»Ñù¡£·ÂÖÆÒ©µÄ¹ã·º...

ÇóÖúDiscovery studioÀ©Õ¹³ÌÐò

Áù½Ç·çÁå
InverseDockingbyLibDock·´ÏòÕÒ°ÐÀ©Õ¹³ÌÐò£¬Ò»¸öС·Ö×Ӻ͵°°×¿â£¨×Ô¼º×¼±¸£©¶Ô½ÓÇóÖúDSÀ©Õ¹³ÌÐò

Ïã¸Û´óѧ»¯Ñ§Ïµ ³ÏÕÐCADD¡¢»¯Ñ§ÐÅϢѧ¡¢AI¸¨ÖúÒ©ÎïÉè¼Æ·½ÏòµÄ˶²©Ñо¿ÉúºÍ²©Ê¿ºó

jiadaigz
Ïã¸Û´óѧ»¯Ñ§ÏµÖ§Ö¾Ã÷ԺʿÑо¿×飬ÏÖÓÐCADD¡¢»¯Ñ§ÐÅϢѧºÍAI¸¨ÖúÒ©ÎïÉè¼Æ·½Ïò£¬³ÏÕÐ˶ʿ/²©Ê¿Ñо¿ÉúºÍ²©Ê¿ºó£¬Èëѧʱ¼ä2021ÄêÇï¼¾»¶Ó­¸ÐÐËȤµÄ±¾¿Æ/˶ʿ/²©Ê¿Í¬Ñ§ÁªÏµ±¨Ãû£¡¸Ãְλ²»½öΪѧÉúÌṩÉè¼ÆºÍÆÀ¹À´´ÐÂËã·¨µÄ»ú»á£¬Ò²»á¸øÑ§ÉúÌṩÔÚÒ©ÎïÑз¢ºÍÁÙ´²Ó¦Ó÷½ÃæÊµ...

×öºÏ³ÉʵÑéµÄ¹¤ÖÖÊÇÌØÊ⹤ÖÖô£¿

zn19831231
×öºÏ³ÉʵÑéµÄ¹¤ÖÖÊÇÌØÊ⹤ÖÖô£¿³£Äê´ÓÊÂÓлúºÏ³ÉÄÜ·ñÊÓÎªÌØÊ⹤ÖÖ£¿

ÔÚÄÄÀïÄÜÂòµ½Ï¸°ûÐü¸¡ÅàÑøÓõÄË«²à±Úϸ°ûÅàÑøÆ¿ÄØ£¿

jukongka
Çë½Ì³æÓÑÃÇ£¬ÔÚÄÄÀïÄÜÂòµ½Ï¸°ûÐü¸¡ÅàÑøÓõÄË«²à±Úϸ°ûÅàÑøÆ¿°¡£¿ÄÇÖÖ´ø´ÅÁ¦½Á°èµÄתƿ£¬Ð»Ð»ÌṩÐÅÏ¢

ÔÚÄÄÀïÄÜÂòµ½Ï¸°ûÐü¸¡ÅàÑøÓõÄË«²à±Úϸ°ûÅàÑøÆ¿ÄØ£¿

jukongka
Çë½Ì³æÓÑÃÇ£¬ÔÚÄÄÀïÄÜÂòµ½Ï¸°ûÐü¸¡ÅàÑøÓõÄË«²à±Úϸ°ûÅàÑøÆ¿°¡£¿ÄÇÖÖ´ø´ÅÁ¦½Á°èµÄתƿ£¬Ð»Ð»ÌṩÐÅÏ¢

¼ÓËÙÎȶ¨ÐÔʵÑéÈôÉ趨ζÈ60¡æ£¬Êª¶ÈÉ趨¶àÉÙÄØ£¿

Æë¹úСҩͯ
ÈçÌ⣬¼ÓËÙÎȶ¨ÐÔʵÑéÈôÉ趨ζÈ60¡æ£¬Êª¶ÈÉ趨¶àÉÙÄØ£¿ÎÒ×öµÄÊÇ¿É×¢É仺ÊÍÖÆ¼Á¡£»¹ÓÐÈô·ÅÖÃÔÚÆÕͨºæÏäµÄ»°£¬Êª¶ÈÈçºÎ¿ØÖÆÄØ£¿Çë´óÀÐÃǴͽ̣¬Ð»Ð»

MAT2AÒÖÖÆ¼ÁAG-270ÈܽâÎÊÌâ

Íõ°²µÏ
ÈçͼËùʾ£¬²Î¿¼ÎÄÏ×"TheDiscoveryofAG-270,aFirst-in-ClassOralMAT2AInhibitorfortheTreatmentofTumorswithHomozygousMTAPDeletion"ÀïÌá¼°ÁËÒ©Îï...
ÏÂÔØÐ¡Ä¾³æAPP
Óë700Íò¿ÆÑдïÈËËæÊ±½»Á÷
  • ¶þάÂë
  • IOS
  • °²×¿